Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Propranolol hydrochloride 10 mg oral tablet |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 40 mg oral tablet |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80 mg oral tablet |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160 mg oral tablet |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de propranolol 1 mg/mL, ampoule de 1 mL de solution pour injection |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 5mg/5mL syrup |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 50mg/5mL syrup |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 10mg/5mL syrup |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 40mg/5mL syrup |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80mg/5mL syrup |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160mg m/r capsule |
Is a |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 5mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de propranolol 1 mg/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 50mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 40mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 120mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Inderal 80mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 4 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 8 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80mg/mL concentrated oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Product containing hydrochlorothiazide and propranolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride + bendrofluazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Propranolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 90 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Propranolol hydrochloride 60mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 120mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 80 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 160 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
2 |
Propranolol hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 90 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 10 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 10 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 1 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely propranolol hydrochloride 1 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 4 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 4 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 8 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 8 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |
Propranolol hydrochloride 80 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Propranolol hydrochloride |
Inferred relationship |
Some |
1 |